ConductScience.org, home

Paper33570554

DPP4 Activity, Hyperinsulinemia, and Atherosclerosis.

Love KM and 1 other. J Clin Endocrinol Metab, 2021. Cited by 45 papers, by iCite.

Cite this record

ConductScience Library. DPP4 Activity, Hyperinsulinemia, and Atherosclerosis. Papers, record 33570554. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33570554

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
DPP4 Activity, Hyperinsulinemia, and Atherosclerosis.
PubMed
Journal
J Clin Endocrinol Metab
PubMed
Year
2021
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Review
PubMed
Citations, by iCite
45
iCite
Relative citation ratio, by iCite
3.03
iCite
Revised in PubMed
2024-11-10
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Love KMKaitlin M
2Liu ZZhenqihttps://orcid.org/0000-0001-5077-0941

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AtherosclerosisMajor topic
Dipeptidyl Peptidase 4Major topic
HyperinsulinismMajor topic
Animals
Cardiovascular Diseases
Humans
Insulin Resistance
Oxidative Stress

Source PubMed

Download CSV of topics

Grants7

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
F32 DK121431NIDDK NIH HHSUnited StatesF32DK121431PubMed and NIHNIH RePORTER
R01 DK124344NIDDK NIH HHSUnited StatesR01DK124344PubMed and NIHNIH RePORTER
KL2 TR003016NCATS NIH HHSUnited StatesKL2TR003016PubMed and NIHNIH RePORTER
R01 DK102359NIDDK NIH HHSUnited StatesR01DK102359PubMed and NIHNIH RePORTER
R01 DK125330NIDDK NIH HHSUnited StatesR01DK125330PubMed and NIHNIH RePORTER
UL1 TR003015NCATS NIH HHSUnited StatesUL1TR003015PubMed and NIHNIH RePORTER
T32 GM145443NIGMS NIH HHSUnited StatesT32GM145443PubMedNIH RePORTER

Download CSV of grants

References130

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
123967137Preventive effect of dipeptidyl peptidase-4 inhibitor on atherosclerosis is mainly attributable to incretin's actions in nondiabetic and diabetic apolipoprotein E-null mice.PLoS One2013https://conductscience.org/library/papers/23967137PubMed
216945366Inhibition of dipeptidyl peptidase-IV activity by metformin enhances the antidiabetic effects of glucagon-like peptide-1.Eur J Pharmacol2006https://conductscience.org/library/papers/16945366PubMed
315235597Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1.Nat Med2004https://conductscience.org/library/papers/15235597PubMed
45134256The effect of insulin on the incorporation of sodium (1- 14 C)-acetate into the lipids of the rat aorta.Diabetologia1971https://conductscience.org/library/papers/5134256PubMed
528244635Effect of linagliptin on pulse wave velocity in early type 2 diabetes: A randomized, double-blind, controlled 26-week trial (RELEASE).Diabetes Obes Metab2017https://conductscience.org/library/papers/28244635PubMed
628232493Glucagon-Like Peptide 1 Protects Pancreatic β-Cells From Death by Increasing Autophagic Flux and Restoring Lysosomal Function.Diabetes2017https://conductscience.org/library/papers/28232493PubMed
726106188Gut Peptides Are Novel Regulators of Intestinal Lipoprotein Secretion: Experimental and Pharmacological Manipulation of Lipoprotein Metabolism.Diabetes2015https://conductscience.org/library/papers/26106188PubMed
810094109Chronic physiologic hyperinsulinemia impairs suppression of plasma free fatty acids and increases de novo lipogenesis but does not cause dyslipidemia in conscious normal rats.Metabolism1999https://conductscience.org/library/papers/10094109PubMed
927173468Anagliptin, a dipeptidyl peptidase-4 inhibitor, decreases macrophage infiltration and suppresses atherosclerosis in aortic and coronary arteries in cholesterol-fed rabbits.Metabolism2016https://conductscience.org/library/papers/27173468PubMed
1026628419
Alogliptin, a Dipeptidyl Peptidase 4 Inhibitor, Prevents the Progression of Carotid Atherosclerosis in Patients With Type 2 Diabetes: The Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A).
Diabetes Care2016https://conductscience.org/library/papers/26628419PubMed
116753751Dipeptidyl peptidase IV inhibits the polymerization of fibrin monomers.Arch Biochem Biophys1982https://conductscience.org/library/papers/6753751PubMed
1223992602Alogliptin after acute coronary syndrome in patients with type 2 diabetes.N Engl J Med2013https://conductscience.org/library/papers/23992602PubMed
1327839908Cellular Sites and Mechanisms Linking Reduction of Dipeptidyl Peptidase-4 Activity to Control of Incretin Hormone Action and Glucose Homeostasis.Cell Metab2017https://conductscience.org/library/papers/27839908PubMed
1415864535Hyperglycaemia increases dipeptidyl peptidase IV activity in diabetes mellitus.Diabetologia2005https://conductscience.org/library/papers/15864535PubMed
1529127241Monocyte DPP4 Expression in Human Atherosclerosis Is Associated With Obesity and Dyslipidemia.Diabetes Care2018https://conductscience.org/library/papers/29127241PubMed
1619805130Insulin resistance is a cellular antioxidant defense mechanism.Proc Natl Acad Sci U S A2009https://conductscience.org/library/papers/19805130PubMed
1711055977Hyperinsulinemia enhances transcriptional activity of nuclear factor-kappaB induced by angiotensin II, hyperglycemia, and advanced glycosylation end products in vascular smooth muscle cells.Circ Res2000https://conductscience.org/library/papers/11055977PubMed
1826080706Liraglutide protects pancreatic β-cells against free fatty acids in vitro and affects glucolipid metabolism in apolipoprotein E-/- mice by activating autophagy.Mol Med Rep2015https://conductscience.org/library/papers/26080706PubMed
1921593202Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome.Diabetes2011https://conductscience.org/library/papers/21593202PubMed
2027357799Linagliptin treatment improves cerebrovascular function and remodeling and restores reduced cerebral perfusion in Type 2 diabetes.Am J Physiol Regul Integr Comp Physiol2016https://conductscience.org/library/papers/27357799PubMed

See all 130 referencesDownload CSV of references

Cited by33

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 45 citations.

PMIDTitleJournalYearIn PapersSource
42528342Neurovascular Actions of Dipeptidyl Peptidase-4 Inhibitors and Their Implications for Cognitive Dysfunction in Type 2 Diabetes Mellitus.Clin Psychopharmacol Neurosci2026https://conductscience.org/library/papers/42528342PubMed
42357514Exploring Active Ingredients and Mechanisms of Crataegi fructus Extract in Alleviating MAFLD via the AMPK/PPAR Pathway by Multi-Omics.Molecules2026https://conductscience.org/library/papers/42357514PubMed
42292215
The predictive value of combined assessment of estimated glucose disposal rate and non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio for cardiovascular disease risk: a nationwide cohort study.
Front Med (Lausanne)2026https://conductscience.org/library/papers/42292215PubMed
42238559Correlation between DPP-4 Gene Expression and T-Cell Subset Marker Genes in Chronic Liver Disease Patients in Eastern India: An Observational Study.Indian J Endocrinol Metab2026https://conductscience.org/library/papers/42238559PubMed
42086715CD8+ T cells in atherosclerosis and coronary artery disease.Nat Rev Cardiol2026https://conductscience.org/library/papers/42086715PubMed
41982775Hepatokines and polycystic ovary syndrome: investigating the connection between the hepato-ovarian axis and disorders in glycolipid metabolism in PCOS: a narrative review.Front Endocrinol (Lausanne)2026https://conductscience.org/library/papers/41982775PubMed
41954023Intersecting Molecular Pathways in Cardiovascular Disease and Diabetes Mellitus: Emerging Roles of Inflammation and Therapeutics.Diabetes Metab Res Rev2026https://conductscience.org/library/papers/41954023PubMed
41908043
Establishing an atherosclerosis diagnostic model based on WGCNA and machine learning algorithms with key genes in cholesterol metabolism and ferroptosis, and revealing the regulatory role of HMOX1 in cellular ferroptosis.
Front Cardiovasc Med2026https://conductscience.org/library/papers/41908043PubMed
41502982Integrative Genetic Analysis of DPP4-Related Variants Reveals Risk Patterns for Type 2 Diabetes and Cardiometabolic Comorbidities.Diabetes Metab Syndr Obes2025https://conductscience.org/library/papers/41502982PubMed
41153047Prognostic impacts of lipoxin A4 in relation to diabetes and insulin resistance in patients with acute myocardial infarction: a prospective study.Diabetol Metab Syndr2025https://conductscience.org/library/papers/41153047PubMed
41085793The effects of DPP4 inhibitors, SGLT2 inhibitors and GLP1-RA on the AGE/RAGE pathway: implications for diabetes and its complications.Glycoconj J2025https://conductscience.org/library/papers/41085793PubMed
40604004Association of urinary dipeptidyl peptidase 4 activity with clinical outcomes in people with chronic kidney disease.Sci Rep2025https://conductscience.org/library/papers/40604004PubMed
40514620Searching for peripheral proteomic markers of primary aldosteronism.Endocrine2025https://conductscience.org/library/papers/40514620PubMed
40016825Metabolic reprogramming of peritoneal mesothelial cells in peritoneal dialysis-associated fibrosis: therapeutic targets and strategies.Cell Commun Signal2025https://conductscience.org/library/papers/40016825PubMed
39696298Association of non-insulin-dependent insulin resistance indices with lower limb artery restenosis after drug-coated balloon angioplasty.Lipids Health Dis2024https://conductscience.org/library/papers/39696298PubMed
39512193Impact of DPP-4 Inhibitors on Interleukin Levels in Type 2 Diabetes Mellitus.J Clin Endocrinol Metab2025https://conductscience.org/library/papers/39512193PubMed
39487484The association between triglyceride-glucose index combined with obesity indicators and stroke risk: A longitudinal study based on CHARLS data.BMC Endocr Disord2024https://conductscience.org/library/papers/39487484PubMed
39329916Biomarkers That Seem to Have the Greatest Impact on Promoting the Formation of Atherosclerotic Plaque in Current Scientific Research.Curr Issues Mol Biol2024https://conductscience.org/library/papers/39329916PubMed
39281431An innovative metabolic index for insulin resistance correlates with early neurological deterioration following intravenous thrombolysis in minor acute ischemic stroke patients.Heliyon2024https://conductscience.org/library/papers/39281431PubMed
39068452The effect of prognostic nutritional index on diabetic patients with myocardial infarction.Diabetol Metab Syndr2024https://conductscience.org/library/papers/39068452PubMed

See all 33 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
DPP41803PubTator's text mininghttps://conductscience.org/library/genes/1803NCBI Gene
INS3630PubTator's text mininghttps://conductscience.org/library/genes/3630NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33570554

GET https://conductscience.org/api/papers/v1/33570554/references?page=2